This P.A.C.E.®-accredited webinar series on Antimicrobial Susceptibility
Testing (AST) in the clinical microbiology laboratory focuses on cases
regarding situations in which specialized susceptibility testing for organisms
other than common, rapidly-growing aerobic bacteria should be performed. Topics include AST for
fastidious bacteria, anaerobic bacteria, yeasts, filamentous fungi, and nontuberculosis mycobacteria. This course will provide a foundation on antifungal and
anti-mycobacterial drug classes, their modes of action, spectrum of activity,
pharmacokinetics/pharmacodynamics (PK/PD), and common mechanisms of resistance. This series will be part three of the ASM-CLSI AST series. Part one and part two of this AST webinar series are currently available on-demand on ASM Events Online.
A chat room will available to bundle purchasers where learners can ask questions and provide comments. Series facilitators may recommend reading specific open access articles based on the conversations and questions asked. A transcript of the Q & A discussion will be available to bundle purchasers once the course is complete.
Single webinar – $35 for ASM & CLSI members/ $47 for non-members
Webinar bundle (all four topics) – $130 ASM & CLSI members/ $174 for non-members
The purchase price includes access to the live event, unlimited access to the recorded presentation for up to twelve months after the live event, and continuing education credit for the purchaser. Purchasers of the bundle receive access to the above mentioned chat room.
Not an ASM member? Join now!
CLSI member? Contact CLSI for the coupon code. The CLSI coupon code cannot be used on top of the ASM member price.
An institutional subscription is available for this course for $259 per webinar. Purchase of institutional subscriptions will allow access and CE credit for up to 10 users. Please call Nicole Jackson at 202-942-9257 to purchase an institutional subscription.
Date(s): Webinars will be presented every other Wednesday at 2:00 pm. (EST) starting October 11, 2017. Live webinars conclude on November 29, 2017. Recordings will be available on-demand for one year following the live presentation.
Continuing Education (CE) Credit: Each presentation is approved for 1.0 P.A.C.E.® credit. ASM is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. All presentations are recognized by the California Department of Health and Florida Department of Health and qualify for California and Florida CE credit toward license renewal. If you watch the live version, you must claim your CE credits within three (3) days. If you do not, you will have to watch the recorded version in order to claim your CE credits. CE credits can only be claimed by the purchaser (individual sales only).
Format: There are four webinars in this series. The webinars' content does not build on the previous webinars in the series. All of the content is independent so learners can purchase only those that meet their needs.
The live webinar’s audio and video are presented via your computer. Learners who listen to the expert’s 50-minute presentation will have the opportunity to ask questions. The presentation will be recorded and available for viewing one week after the live event. Learners will receive an email once the recording is available. If you purchase a topic after the live event, you will only have access to the recording.
This educational series made possible through an unrestricted education grant from Accelerate Diagnostics.
If you require closed captioning, please send in your request for captions at least one week prior to the live webinar(s) you plan to attend. If you need captions for archived webinars in this series, please include it in your email and ASM will accommodate your request.
Antibiotic Susceptibility Testing Direct from Positive Blood Cultures: Challenges and Opportunities for Pediatric and Immunocompromised Patients with Bacteremia
Antibiotic Susceptibility Testing Direct from Positive Blood Cultures: Challenges and Opportunities in the Academic Medical Center Setting
Providing phenotypic antimicrobial susceptibility results to clinicians can significantly affect patient outcomes and is, arguably, one of the most important activities performed by clinical microbiology laboratories. This symposium focused on direct from positive blood culture phenotypic antibiotic susceptibility testing and the challenges and opportunities in integrating this new technology into antimicrobial stewardship programs. Additionally, presenters discussed the impact of early susceptibility results on the management patients with Gram-negative bacteremia.
If you are purchasing all four topics click this “Add to Cart” to get the bundle price. Adding all topics to your cart individually will result in a higher fee.